Maternal and Infant Supplementation with Small-Quantity Lipid-Based Nutrient Supplements Increases Infants’ Iron Status at 18 Months of Age in a Semiurban Setting in Ghana: A Secondary Outcome Analysis of the iLiNS-DYAD Randomized Controlled Trial
dc.contributor.author | Adu-Afarwuah, S. | |
dc.contributor.author | Young, R.T. | |
dc.contributor.author | Lartey, A. | |
dc.contributor.author | Okronipa, H. | |
dc.contributor.author | Ashorn, P. | |
dc.contributor.author | Ashorn, U. | |
dc.contributor.author | Oaks, B.M. | |
dc.contributor.author | Arimond, M. | |
dc.contributor.author | Dewey, K.G. | |
dc.date.accessioned | 2019-05-24T09:40:51Z | |
dc.date.available | 2019-05-24T09:40:51Z | |
dc.date.issued | 2019-01 | |
dc.description.abstract | Background Interventions are needed to address iron deficiency in low-income settings. Objective This secondary outcome analysis aimed to compare the hemoglobin (Hb) and iron status [zinc protoporphyrin (ZPP)] of children born to women enrolled in the iLiNS-DYAD trial in Ghana. Methods Women ≤20 wk pregnant (n = 1320) were assigned to receive 60 mg Fe/d and 400 µg folic acid/d until delivery and placebo thereafter, and no supplementation for infants (IFA group); or multiple micronutrients containing 20 mg Fe/d until 6 mo postpartum and no supplementation for infants (MMN); or small-quantity lipid-based nutrient supplements (SQ-LNSs) containing 20 mg Fe/d until 6 mo postpartum, and SQ-LNSs for infants from 6 to 18 mo of age (LNS). We compared infants’ Hb (g/L) and ZPP (µmol/mol heme) at 6 and 18 mo of age. Results At 6 mo of age, groups did not differ in mean ± SD Hb (overall: 113 ± 9.9 g/L) or geometric mean (95% CI) ZPP [overall: 62.6 (60.6, 64.7)]. At 18 mo of age, mean ± SD Hb (overall: 112 ± 10.4 g/L) did not differ significantly between groups, whereas geometric mean (95% CI) ZPP was lower (P = 0.031) in the LNS group [53.9 (50.7, 57.3)] than the IFA [60.4 (56.7, 64.3)] but not the MMN [58.8 (55.6, 62.2)] group. Further, the LNS group, compared with the IFA and MMN groups combined, had a lower prevalence of elevated (>70) ZPP (27.5% compared with 35%; P = 0.02) and a marginally lower prevalence of anemia (38.7% compared with 44.9%; P = 0.06). These results generally remained unchanged when controlling for prespecified covariates or correcting for inflammation. Conclusions In this setting, providing SQ-LNSs or multiple micronutrients with 20 mg Fe/d, compared with iron (60 mg/d) and folic acid, to pregnant women does not affect their infants’ Hb or iron status at 6 mo of age, but maternal and infant supplementation with SQ-LNSs increases infants’ iron status at 18 mo of age. This trial was registered at clinicaltrials.gov as NCT00970866. | en_US |
dc.identifier.other | https://doi.org/10.1093/jn/nxy225 | |
dc.identifier.other | Volume 149, Issue 1, Pages 149–158 | |
dc.identifier.uri | http://ugspace.ug.edu.gh/handle/123456789/30267 | |
dc.language.iso | en | en_US |
dc.publisher | Journal of Nutrition | en_US |
dc.subject | Micronutrient supplementation | en_US |
dc.subject | Iron and folic acid | en_US |
dc.subject | Multiple micronutrient supplements | en_US |
dc.subject | Small-quantitylipid-based nutrient supplements | en_US |
dc.subject | Infants | en_US |
dc.title | Maternal and Infant Supplementation with Small-Quantity Lipid-Based Nutrient Supplements Increases Infants’ Iron Status at 18 Months of Age in a Semiurban Setting in Ghana: A Secondary Outcome Analysis of the iLiNS-DYAD Randomized Controlled Trial | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Maternal and Infant Supplementation with Small-Quantity Lipid-Based Nutrient Supplements Increases Infants’ Iron Status at 18 Months of Age in a Semiurban Setting in Ghana A Secondary Outcome Analysis of the iLiNS-DYAD Rand.pdf
- Size:
- 703.82 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.6 KB
- Format:
- Item-specific license agreed upon to submission
- Description: